Clinical trial

Ondansetron Reduce Vomiting Associated With Ketamine PSA

NCT00387556 · University of Colorado, Denver, Other · Completed

Key facts

NCT number NCT00387556
Title Ondansetron Reduce Vomiting Associated With Ketamine PSA
Official title Does Ondansetron Reduce the Incidence of Vomiting When Used in Conjunction With Ketamine During Procedural Sedation in the Pediatric Emergency Department
Lead sponsor University of Colorado, Denver, Other
Status Completed
Study type Interventional
Conditions Conscious Sedation
Intervention type Drug
Interventions Ondansetron
Enrollment 268
Start date Dec 1, 2002
Primary completion Dec 1, 2006
Completion Dec 1, 2006
First posted Oct 13, 2006
Last update posted May 13, 2013
Countries United States

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies